AGEN (Agenus) Short-Term Debt to Capital
The price action of Agenus (AGEN) reflects the current 0.00 indicator. The business relies on the creation of a closed antibody discovery system designed for long-term partnerships with big pharma behemoths. Agenus minimizes costs through the in-house production of vaccines and anti-tumor drugs. Currently, the primary focus has shifted toward finalizing documentation and analyzing results from late-stage trials of treatments for solid tumors.
Analytical breakdowns for Agenus
- stock quotes and analyst forecast:
- business market valuation indicators:
- book capitalization information:
- company liabilities and liquidity data:
- company profitability and valuation multiples indicators:
Fundamental valuation:Agenus Inc
Agenus occupies a strategic niche in immuno-oncology, leveraging synergies with behemoths such as Bristol Myers Squibb. By analyzing changes in the short-term debt-to-equity ratio, an investor can see the proportion of liabilities due within one year relative to equity. This metric determines liquidity management efficiency and the degree of dependence on rapid refinancing. Minimizing this ratio confirms the company's financial stability when implementing costly joint research projects.
Main competitors
Short-Term Debt to Capital ARGX|BNTX (BioNTech Pharma) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital ABVX (Abivax Pharma)|Short-Term Debt to Capital admabiologics.com ADMA|PTGX - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital IMVT (Immunovant Inc)|Kiniksa Pharmaceuticals Ltd (KNSA) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Grifols Biemat|ADPT (Adaptive Biotechnologies) - Short-Term Debt to Capital|Short-Term Debt to Capital celldex.com|Short-Term Debt to Equity Ratio AUPH (Aurinia Pharmaceuticals Inc.)|BCRX (BioCryst Pharmaceuticals, Inc.) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VERA (Vera Pharma)|Short-Term Debt to Capital Coefficient Dianthus Corp (DNTH)|PHVS - Short-Term Debt to Equity|AbCellera Biologics Inc (ABCL) - Short-Term Debt to Equity Ratio|Tourmaline Bio (TRML) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Precigen Inc|Short-Term Debt to Equity Ratio PHAR|Short-Term Debt to Capital Nektar Corp|Short-Term Debt to Equity Upstream Bio Inc (UPB)|zenasbio.com - Short-Term Debt to Capital Ratio|Short-Term Debt to Capital IMNM (Immunome)|Gossamer Bio Inc (GOSS) - Current Liabilities to Capital|KalVista Pharmaceuticals Inc - Short-Term Debt to Capital|SEPN - Short-Term Debt to Capital|PVLA: Short-Term Debt to Capital|Short-Term Indebtedness to Equity savarapharma.com SVRA|RIGL (Rigel Pharmaceuticals, Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital AnaptysBio Inc ANAB|Short-Term Debt to Equity Astria Pharma (ATXS)|enGene Corp - Short-Term Debt to Capital Ratio|RAPT Therapeutics - Short-Term Debt to Equity Ratio|Short-Term Debt to Capital Aerovate Therapeutics, Inc. JBIO|ACRS - Short-Term Debt to Equity|Short-Term Debt to Capital Coefficient Kyverna Therapeutics Inc. KYTX|TLSA: Short-Term Debt to Capital|Cabaletta Bio Inc (CABA) - Short-Term Debt to Capital|VTYX (Ventyx Biosciences) - Short-Term Debt to Capital|THTX - Short-Term Indebtedness to Equity|Short-Term Debt to Capital AVTX|ELDN - Current Liabilities to Capital|Short-Term Debt to Equity Climb Bio, Inc. CLYM|ZURA: Short-Term Debt to Capital Ratio|ATYR - Short-Term Debt to Equity|Current Liabilities to Equity ADAG|IMA: Short-Term Debt to Capital|Shattuck Labs - Ratio of Short-Term Indebtedness to Capital|EQ (Equillium Inc) - Short-Term Debt to Capital|Short-Term Debt to Capital Connect Pharma|Short-Term Debt to Equity Immunic, Inc. (IMUX)|ATRA (atarabio.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity InflaRx IFRX|XFOR - Short-Term Debt to Equity Ratio|Adicet - Short-Term Debt to Capital|CELU - Short-Term Debt to Capital|INMB (INmune Bio, Inc.) - Short-Term Debt to Equity Ratio|barinthusbio.com - Ratio of Short-Term Indebtedness to Capital|KZR (Kezar Life Sciences, Inc.) - Short-Term Debt to Capital|SAB Biotherapeutics Inc. (SABS) - Short-Term Debt to Capital Coefficient|Short-Term Debt to Equity Akari Therapeutics plc (AKTX)|Short-Term Debt to Equity Ratio enlivex.com ENLV|Short-Term Debt to Equity Q32 Bio QTTB|GOVX - Short-Term Debt to Equity Ratio|EDSA: Short-Term Debt to Equity Ratio|IBIO - Short-Term Debt to Capital|carismatx.com (CARM) - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio XTLB|BOLT (Bolt Biotherapeutics Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital HCW Biologics Inc HCWB|Short-Term Debt to Capital APVO|Short-Term Debt to Capital aimimmuno.com (AIM)|Short-Term Debt to Capital ADTX (Aditxt, Inc.)|Short-Term Indebtedness to Equity GRI Bio Corporation|XORTX Therapeutics Inc. - Short-Term Debt to Capital|Current Liabilities to Capital reshapelifesciences.com|Revelation Biosciences, Inc. (REVB) - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio INDP|Short-Term Debt to Equity Ratio SCNI|Short-Term Debt to Capital CalciMedica Corp|Short-Term Debt to Equity Affimed (AFMD)|Short-Term Debt to Capital Coefficient allakos.com|Short-Term Debt to Capital HOOK (HOOKIPA Pharma)|Short-Term Debt to Capital IGM Biosciences Inc. IGMS|iTeos - Short-Term Debt to Capital|Short-Term Indebtedness to Equity Ocean Biomedical Corp (OCEA)|TCBP: Short-Term Debt to Capital|Current Liabilities to Capital thirdharmonicbio.com (THRD)